Uber’s leadership is back in the legal hot seat in its hometown, as shareholders filed a federal lawsuit today accusing the company’s board of directors of deliberately looking the other way on compliance and oversight failures that, they say, helped pave the way for thousands of sexual-assault and harassment claims. The complaint, lodged in federal court in San Francisco, names CEO Dara Khosrowshahi and several other directors as defendants and seeks to hold the board accountable for what it calls having knowingly cut compliance corners. According to the plaintiffs, the alleged gaps were not random slip-ups but systemic decisions that left riders at risk and Uber staring down long-term legal exposure.
What the lawsuit alleges
The suit, as reported by Reuters, claims the board repeatedly chose growth and legal maneuvering over building robust systems to prevent misconduct, which plaintiffs argue left riders vulnerable and the company facing thousands of claims. The shareholders are seeking damages along with corporate-governance reforms, asserting that directors failed to put in place or enforce adequate compliance programs and brushed off warning signs. Uber did not immediately respond to requests for comment.
Behind the filing: a growing docket
The new complaint lands on top of an already crowded litigation calendar. Thousands of passenger sexual-assault lawsuits have been consolidated in federal and state proceedings, and recent trial outcomes have only heightened settlement pressure. The Los Angeles Times reported that more than 3,100 federal cases, along with hundreds of state claims, have been centralized in the Northern District of California. In February, a federal jury in Arizona awarded $8.5 million in a bellwether case, a verdict that advocates say raised the stakes for Uber, according to The Associated Press.
Legal stakes for directors
The shareholder complaint appears to be a derivative action that accuses directors of breaching fiduciary duties through oversight failures. Under Delaware law, those kinds of allegations typically fall into the Caremark framework, which can expose directors only when there is a sustained or systematic failure to monitor compliance. Legal analysts note that Caremark claims are notoriously hard to plead, although courts have allowed some to move forward when plaintiffs point to persistent red flags or repeated warnings that were allegedly ignored. Plaintiffs in this case are expected to seek broad discovery into board minutes, safety reports, and executive communications. An overview of the oversight standard is outlined by DLA Piper.
What comes next
Procedurally, the suit will first have to clear early hurdles, including anticipated motions to dismiss and potential arguments that shareholders should have made a formal demand on the board before filing. If it survives that phase, the case is likely to move into merits discovery, with depositions of executives and directors and requests for internal safety data that have already featured prominently in recent bellwether trials. The directors are expected to lean on business-judgment deference and directors-and-officers insurance in their defense, but the litigation could still drive governance changes and intensify scrutiny from investors and regulators.
